annual operating expenses:
$1.90B+$365.40M(+23.76%)Summary
- As of today (August 23, 2025), GMAB annual total operating expenses is $1.90 billion, with the most recent change of +$365.40 million (+23.76%) on December 31, 2024.
- During the last 3 years, GMAB annual operating expenses has risen by +$2.38 billion (+496.83%).
- GMAB annual operating expenses is now at all-time high.
Performance
GMAB Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$514.44M+$29.11M(+6.00%)Summary
- As of today (August 23, 2025), GMAB quarterly total operating expenses is $514.44 million, with the most recent change of +$29.11 million (+6.00%) on June 1, 2025.
- Over the past year, GMAB quarterly operating expenses has increased by +$24.35 million (+4.97%).
- GMAB quarterly operating expenses is now -8.07% below its all-time high of $559.60 million, reached on December 31, 2024.
Performance
GMAB quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GMAB Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | +5.0% |
| 3 y3 years | +496.8% | +388.4% |
| 5 y5 years | +581.3% | +177.5% |
GMAB Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +313.7% | -8.1% | +240.8% |
| 5 y | 5-year | at high | +297.2% | -8.1% | +177.5% |
| alltime | all time | at high | +297.2% | -8.1% | +177.5% |
GMAB Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $514.44M(+6.0%) |
| Mar 2025 | - | $485.33M(-13.3%) |
| Dec 2024 | $1.90B(+23.8%) | $559.60M(+20.7%) |
| Sep 2024 | - | $463.53M(-5.4%) |
| Jun 2024 | - | $490.09M(+6.6%) |
| Mar 2024 | - | $459.56M(+10.6%) |
| Dec 2023 | $1.54B(-272.7%) | $415.58M(-3.4%) |
| Sep 2023 | - | $430.28M(+9.9%) |
| Jun 2023 | - | $391.52M(-751.3%) |
| Mar 2023 | - | -$60.11M(-83.6%) |
| Dec 2022 | -$890.71M(+85.7%) | -$365.46M(+39.9%) |
| Sep 2022 | - | -$261.31M(+46.5%) |
| Jun 2022 | - | -$178.39M(+130.2%) |
| Mar 2022 | - | -$77.50M(-37.7%) |
| Dec 2021 | -$479.66M(-50.3%) | -$124.33M(-11.9%) |
| Sep 2021 | - | -$141.07M(+10.6%) |
| Jun 2021 | - | -$127.59M(+48.1%) |
| Mar 2021 | - | -$86.16M(-39.4%) |
| Dec 2020 | -$965.40M(+144.1%) | -$142.07M(+5.5%) |
| Sep 2020 | - | -$134.70M(-79.7%) |
| Jun 2020 | - | -$664.04M(+6243.0%) |
| Mar 2020 | - | -$10.47M(-96.8%) |
| Dec 2019 | -$395.46M(+81.0%) | -$322.46M(+517.1%) |
| Sep 2019 | - | -$52.25M(+153.1%) |
| Jun 2019 | - | -$20.64M(-623.4%) |
| Mar 2019 | - | $3.94M(-103.6%) |
| Dec 2018 | -$218.48M(+5.4%) | -$110.26M(+253.1%) |
| Sep 2018 | - | -$31.23M(+44.6%) |
| Jun 2018 | - | -$21.59M(-59.6%) |
| Mar 2018 | - | -$53.48M(-51.9%) |
| Dec 2017 | -$207.19M(+32.5%) | -$111.27M(+1108.5%) |
| Sep 2017 | - | -$9.21M(-88.4%) |
| Jun 2017 | - | -$79.43M(+1102.7%) |
| Mar 2017 | - | -$6.60M(-93.6%) |
| Dec 2016 | -$156.43M(+89.9%) | -$102.55M(+266.0%) |
| Sep 2016 | - | -$28.02M(+30.2%) |
| Jun 2016 | - | -$21.52M(+791.2%) |
| Mar 2016 | - | -$2.41M(-95.6%) |
| Dec 2015 | -$82.39M(+74.6%) | -$55.07M(+159.1%) |
| Sep 2015 | - | -$21.25M(+263.7%) |
| Jun 2015 | - | -$5.84M(-1281.1%) |
| Mar 2015 | - | $494.70K(-104.8%) |
| Dec 2014 | -$47.19M(-145.5%) | -$10.27M(-58.5%) |
| Sep 2014 | - | -$24.77M(-525.1%) |
| Jun 2014 | - | $5.83M(-132.9%) |
| Mar 2014 | - | -$17.69M(-159.6%) |
| Dec 2013 | $103.72M(+2.5%) | $29.70M(-3634.8%) |
| Sep 2013 | - | -$840.10K(-126.9%) |
| Jun 2013 | - | $3.13M(-160.9%) |
| Mar 2013 | - | -$5.14M(-117.6%) |
| Dec 2012 | $101.15M | $29.18M(+533.1%) |
| Sep 2012 | - | $4.61M(-39.5%) |
| Jun 2012 | - | $7.62M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.05M(-70.8%) |
| Dec 2011 | $109.14M(+2555.1%) | $27.59M(+152.3%) |
| Sep 2011 | - | $10.93M(-14.5%) |
| Jun 2011 | - | $12.78M(+11.0%) |
| Mar 2011 | - | $11.51M(-26.9%) |
| Dec 2010 | $4.11M(-97.8%) | $15.75M(-153.5%) |
| Sep 2010 | - | -$29.42M(-285.2%) |
| Jun 2010 | - | $15.89M(-41.0%) |
| Mar 2010 | - | $26.95M(-456.1%) |
| Dec 2009 | $188.67M(-31.1%) | -$7.57M(-115.1%) |
| Sep 2009 | - | $50.08M(-7.9%) |
| Jun 2009 | - | $54.40M(+1.1%) |
| Mar 2009 | - | $53.79M(-26.2%) |
| Dec 2008 | $273.73M(+55.3%) | - |
| Dec 2008 | - | $72.85M(+2.2%) |
| Sep 2008 | - | $71.28M(-5.6%) |
| Jun 2008 | - | $75.50M(+3.3%) |
| Mar 2008 | - | $73.07M(+191.4%) |
| Dec 2007 | $176.22M(+76.0%) | - |
| Dec 2007 | - | $25.08M(-29.0%) |
| Sep 2007 | - | $35.34M(+1390.5%) |
| Jun 2007 | - | $2.37M(-87.3%) |
| Mar 2007 | - | $18.70M(-28.0%) |
| Dec 2006 | $100.13M(+21.7%) | - |
| Dec 2006 | - | $25.96M(+11.2%) |
| Sep 2006 | - | $23.34M(+47.4%) |
| Jun 2006 | - | $15.84M(+3.5%) |
| Mar 2006 | - | $15.31M(-8.2%) |
| Dec 2005 | $82.27M(+22.7%) | - |
| Dec 2005 | - | $16.67M(+0.7%) |
| Sep 2005 | - | $16.55M(-12.9%) |
| Jun 2005 | - | $18.99M(-0.1%) |
| Mar 2005 | - | $19.00M(-18.3%) |
| Dec 2004 | $67.07M(+25.9%) | - |
| Dec 2004 | - | $23.27M(+32.9%) |
| Sep 2004 | - | $17.51M(-4.0%) |
| Jun 2004 | - | $18.24M(+10.1%) |
| Mar 2004 | - | $16.57M(-19.4%) |
| Dec 2003 | $53.26M(-4.4%) | - |
| Dec 2003 | - | $20.57M(+754.1%) |
| Sep 2003 | - | $2.41M(+19.2%) |
| Jun 2003 | - | $2.02M(-19.7%) |
| Mar 2003 | - | $2.52M(-88.2%) |
| Dec 2002 | $55.72M(+117.8%) | - |
| Dec 2002 | - | $21.24M(+63.3%) |
| Sep 2002 | - | $13.00M(+20.7%) |
| Jun 2002 | - | $10.78M(-4.0%) |
| Mar 2002 | - | $11.22M(+3.8%) |
| Dec 2001 | $25.59M(+257.7%) | $10.82M(+33.7%) |
| Sep 2001 | - | $8.09M(+26.2%) |
| Jun 2001 | - | $6.41M(+93.9%) |
| Mar 2001 | - | $3.31M |
| Dec 2000 | $7.15M(+164.8%) | - |
| Dec 1999 | $2.70M | - |
FAQ
- What is Genmab A/S annual total operating expenses?
- What is the all time high annual operating expenses for Genmab A/S?
- What is Genmab A/S annual operating expenses year-on-year change?
- What is Genmab A/S quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Genmab A/S?
- What is Genmab A/S quarterly operating expenses year-on-year change?
What is Genmab A/S annual total operating expenses?
The current annual operating expenses of GMAB is $1.90B
What is the all time high annual operating expenses for Genmab A/S?
Genmab A/S all-time high annual total operating expenses is $1.90B
What is Genmab A/S annual operating expenses year-on-year change?
Over the past year, GMAB annual total operating expenses has changed by +$365.40M (+23.76%)
What is Genmab A/S quarterly total operating expenses?
The current quarterly operating expenses of GMAB is $514.44M
What is the all time high quarterly operating expenses for Genmab A/S?
Genmab A/S all-time high quarterly total operating expenses is $559.60M
What is Genmab A/S quarterly operating expenses year-on-year change?
Over the past year, GMAB quarterly total operating expenses has changed by +$24.35M (+4.97%)